@article{cf2e8409a6a84969ae4e5b4ebd8aae57,
title = "Bipolar I and bipolar II subtypes in older age: Results from the Global Aging and Geriatric Experiments in Bipolar Disorder (GAGE-BD) project",
abstract = "Objectives: The distinction between bipolar I disorder (BD-I) and bipolar II disorder (BD-II) has been a topic of long-lasting debate. This study examined differences between BD-I and BD-II in a large, global sample of OABD, focusing on general functioning, cognition and somatic burden as these domains are often affected in OABD. Methods: Cross-sectional analyses were conducted with data from the Global Aging and Geriatric Experiments in Bipolar Disorder (GAGE-BD) database. The sample included 963 participants aged ≥50 years (714 BD-I, 249 BD-II). Sociodemographic and clinical factors were compared between BD subtypes including adjustment for study cohort. Multivariable analyses were conducted with generalized linear mixed models (GLMMs) and estimated associations between BD subtype and (1) general functioning (GAF), (2) cognitive performance (g-score) and (3) somatic burden, with study cohort as random intercept. Results: After adjustment for study cohort, BD-II patients more often had a late onset ≥50 years (p = 0.008) and more current severe depression (p = 0.041). BD-I patients were more likely to have a history of psychiatric hospitalization (p < 0.001) and current use of anti-psychotics (p = 0.003). Multivariable analyses showed that BD subtype was not related to GAF, cognitive g-score or somatic burden. Conclusion: BD-I and BD-II patients did not differ in terms of general functioning, cognitive impairment or somatic burden. Some clinical differences were observed between the groups, which could be the consequence of diagnostic definitions. The distinction between BD-I and BD-II is not the best way to subtype OABD patients. Future research should investigate other disease specifiers in this population.",
keywords = "bipolar disorder, cognition, comorbidities, diagnostic subtypes, elderly, functioning, geriatrics, impairment, older-age bipolar disorder (OABD), psychiatry",
author = "Beunders, {Alexandra J. M.} and Federica Klaus and Kok, {Almar A. L.} and Schouws, {Sigfried N. T. M.} and Kupka, {Ralph W.} and Blumberg, {Hilary P.} and Farren Briggs and Eyler, {Lisa T.} and Forester, {Brent P.} and Forlenza, {Orestes V.} and Ariel Gildengers and Esther Jimenez and Mulsant, {Benoit H.} and Patrick, {Regan E.} and Soham Rej and Martha Sajatovic and Kaylee Sarna and Ashley Sutherland and Joy Yala and Eduard Vieta and Villa, {Luca M.} and Korten, {Nicole C. M.} and Annemieke Dols",
note = "Funding Information: This project was supported by the International Society for Bipolar Disorders (ISBD) Bowden Massey Strategic Research Initiative; US National Institute of Mental Health (R01MH070902, R01MH113230, R01MH084921); Pfizer; Glaxo Smith Kline; Merck; National Health and Medical Research Council of Australia; National Institute for Biomarker Research in Neuropsychiatry, INBION (FAPESP 14/50873–3; 2016/01302–9 and CNPq 465412/2014–9); Associa{\c c}{\~a}o Beneficente Alzira Denise Hertzog da Silva (ABADHS); Canadian Institutes for Health Research, grant 200017; Ministry of Science and Technology, Taiwan; Spanish Ministry of Science and Innovation (PI15/00283, PI18/00805) integrated into the Plan Nacional de I + D + I and co‐financed by the ISCIII‐Subdirecci{\'o}n General de Evaluaci{\'o}n and the Fondo Europeo de Desarrollo Regional (FEDER); the Instituto de Salud Carlos III; the CIBER of Mental Health (CIBERSAM); the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement (2017 SGR 1365); the CERCA Programme; and the Departament de Salut de la Generalitat de Catalunya for the PERIS grant SLT006/17/00357. This publication's contents are solely the responsibility of the authors and do not necessarily represent the official views of ISBD. The ISBD is a 401c3 non‐profit organization whose mission is to foster international collaboration in education and research. For more information, visit www.isbd.org and www.gage‐bd.org . Funding Information: The authors are deeply grateful to Dr. Charles L. Bowden, who passed away in March of 2022, and his wife Virginia Massey Bowden, for establishing the Bowden Massey Research Initiative, which has supported the GAGE-BD project. Dr. Bowden's deep commitment to advancing care for individuals living with bipolar disorder is a continuously inspiring presence to our GAGE-BD study team and the broader community of scientists focused on research in bipolar disorder. The authors thank Karin de Gooijer, Chien-Lin Su, Julia Binnewies, Yuri Milaneschi, and Mariska Bot for their valuable input. Publisher Copyright: {\textcopyright} 2022 The Authors. Bipolar Disorders published by John Wiley & Sons Ltd.",
year = "2023",
month = feb,
doi = "https://doi.org/10.1111/bdi.13271",
language = "English",
volume = "25",
pages = "43--55",
journal = "Bipolar disorders",
issn = "1398-5647",
publisher = "Blackwell Munksgaard",
number = "1",
}